Filtered By:
Education: Study
Therapy: Stem Cell Therapy

This page shows you your search results in order of relevance. This is page number 3.

Order by Relevance | Date

Total 1233 results found since Jan 2013.

Novel treatment for stroke and possibly other neurological diseases
In this study we pioneered a totally new treatment for stroke, and possibly for all neurological disease," says Michael Chopp, Ph.D., scientific director of the Henry Ford Neuroscience Institute. The new study is published online in the current issue of Journal of Cerebral Blood Flow and Metabolism...
Source: Health News from Medical News Today - August 29, 2013 Category: Consumer Health News Tags: Stroke Source Type: news

Reparative Therapy for Acute Ischemic Stroke with Allogeneic Mesenchymal Stem Cells from Adipose Tissue: A Safety Assessment
Few studies have evaluated the possible beneficial effect of the administration of stem cells in the early stages of stroke. Intravenous administration of allogeneic mesenchymal stem cells (MSCs) from adipose tissue in patients with acute stroke could be a safe therapy for promoting neurovascular unit repair, consequently supporting better functional recovery. We aim to assess the safety and efficacy of MSC administration and evaluate its potential as a treatment for cerebral protection and repair.
Source: Journal of Stroke and Cerebrovascular Diseases - October 7, 2014 Category: Neurology Authors: Exuperio Díez-Tejedor, María Gutiérrez-Fernández, Patricia Martínez-Sánchez, Berta Rodríguez-Frutos, Gerardo Ruiz-Ares, Manuel Lara Lara, Blanca Fuentes Gimeno Source Type: research

MicroRNA cluster miR-17-92 Cluster in Exosomes Enhance Neuroplasticity and Functional Recovery After Stroke in Rats Basic Sciences
Conclusions—Our data suggest that treatment of stroke with tailored exosomes enriched with the miR-17–92 cluster increases neural plasticity and functional recovery after stroke, possibly via targeting phosphatase and tensin homolog to activate the PI3K/protein kinase B/mechanistic target of rapamycin/glycogen synthase kinase 3β signaling pathway.
Source: Stroke - February 26, 2017 Category: Neurology Authors: Hongqi Xin, Mark Katakowski, Fengjie Wang, Jian-Yong Qian, Xian Shuang Liu, Meser M. Ali, Benjamin Buller, Zheng Gang Zhang, Michael Chopp Tags: Animal Models of Human Disease, Cell Signaling/Signal Transduction, Cell Therapy, Stem Cells, Translational Studies Original Contributions Source Type: research

Getting Closer to an Effective Intervention of Ischemic Stroke: The Big Promise of Stem Cell
AbstractStem cell therapy for ischemic stroke has widely been explored. Results from both preclinical and clinical studies have immensely supported the judicious use of stem cells as therapy. These provide an attractive means for preserving and replacing the damaged brain tissues following an ischemic attack. Since the past few years, researchers have used various types of stem cells to replenish insulted neuronal and glial cells in neurological disorders. In the present review, we discuss different types of stem cells employed for the treatment of ischemic stroke and mechanisms and challenges these cells face once introdu...
Source: Translational Stroke Research - October 26, 2017 Category: Neurology Source Type: research

Cell Therapy in Stroke —Cautious Steps Towards a Clinical Treatment
AbstractIn the future, stroke patients may receive stem cell therapy as this has the potential to restore lost functions. However, the development of clinically deliverable therapy has been slower and more challenging than expected. Despite recommendations by STAIR and STEPS consortiums, there remain flaws in experimental studies such as lack of animals with comorbidities, inconsistent approaches to experimental design, and concurrent rehabilitation that might lead to a bias towards positive results. Clinical studies have typically been small, lacking control groups as well as often without clear biological hypotheses to g...
Source: Translational Stroke Research - November 17, 2017 Category: Neurology Source Type: research

Stroke Recovery Aided By Stem Cells
Stem cells from bone marrow or fat improve recovery after stroke in rats, finds a study published in BioMed Central's open access journal Stem Cell Research & Therapy. Treatment with stem cells improved the amount of brain and nerve repair and the ability of the animals to complete behavioural tasks. Stem cell therapy holds promise for patients but there are many questions which need to be answered, regarding treatment protocols and which cell types to use. This research attempts to address some of these questions...
Source: Health News from Medical News Today - January 28, 2013 Category: Consumer Health News Tags: Stroke Source Type: news

Hypoxic-ischemic neonatal encephalopathy: animal experiments for neuroprotective therapies.
Authors: Sameshima H, Ikenoue T Abstract Hypoxic-ischemic neonatal encephalopathy and ensuing brain damage is still an important problem in modern perinatal medicine. In this paper, we would like to share some of the results of our recent studies on neuroprotective therapies in animal experiments, as well as some literature reviews. From the basic animal studies, we have now obtained some possible candidates for therapeutic measures against hypoxic-ischemic neonatal encephalopathy. For example, they are hypothermia, rehabilitation, free radical scavenger, neurotrophic factors and growth factors, steroid, calcium ch...
Source: Stroke Research and Treatment - December 2, 2014 Category: Neurology Tags: Stroke Res Treat Source Type: research

Medical News Today: Brain cells restored by stem cell therapy following stroke, neurological diseases
In a new mouse study, researchers demonstrate how a stem cell therapy increases nerve cell production in mice with stroke-induced brain damage.
Source: Health News from Medical News Today - August 22, 2016 Category: Consumer Health News Tags: Stroke Source Type: news

Letter by Clark Regarding Article, “Clinical Outcomes of Transplanted Modified Bone Marrow-Derived Mesenchymal Stem Cells in Stroke: A Phase 1/2a Study” Letter to the Editor
Source: Stroke - November 27, 2016 Category: Neurology Authors: Ian A. Clark Tags: Ischemic Stroke Letters to the Editor Source Type: research

Response by Steinberg et al to Letter Regarding Article, “Clinical Outcomes of Transplanted Modified Bone Marrow-Derived Mesenchymal Stem Cells in Stroke: A Phase 1/2A Study” Letter to the Editor
Source: Stroke - November 27, 2016 Category: Neurology Authors: Gary K. Steinberg, Douglas Kondziolka, Damien Bates, on behalf of the SB623 Stroke Phase 1/2A Study Group Tags: Stem Cells Letters to the Editor Source Type: research

Accelerating Cell Therapy for Stroke in Japan Special Reports
Source: Stroke - March 26, 2018 Category: Neurology Authors: Kiyohiro Houkin, Hideo Shichinohe, Koji Abe, Teruyo Arato, Mari Dezawa, Osamu Honmou, Nobutaka Horie, Yasuo Katayama, Kohsuke Kudo, Satoshi Kuroda, Tomohiro Matsuyama, Ichiro Miyai, Izumi Nagata, Kuniyasu Niizuma, Ken Sakushima, Masanori Sasaki, Norihiro Tags: Cell Therapy, Clinical Studies, Stem Cells, Translational Studies, Ischemic Stroke Special Report Source Type: research

Application of Mesenchymal Stem Cell-Derived Extracellular Vesicles for Stroke: Biodistribution and MicroRNA Study
In this study, we investigated the biodistribution, therapeutic efficacy, and mode of action of MSC-EVs in a rat stroke model. MSC-EVs successfully stimulated neurogenesis and angiogenesis in vivo. When compared to the MSC-treated group, rats treated with MSC-EVs exhibited greater behavioral improvements than the control group (p <  0.05). Our biodistribution study using fluorescence-labeled MSC-EVs and MSCs demonstrated that the amounts of MSC-EVs in the infarcted hemisphere increased in a dose-dependent manner, and were rarely found in the lung and liver. In addition, MSC-EVs were highly inclusive of various prote...
Source: Translational Stroke Research - October 19, 2018 Category: Neurology Source Type: research

Dental Pulp Stem Cell Therapy in Ischemic Stroke: A Meta-Analysis of Preclinical Studies
More preclinical research evidence has shown that dental pulp stem cells (DPSCs) transplantation is expected to promote the recovery of ischemic stroke (IS), but it still lacks an evidence-based analysis. The purpose of this study was to investigate the effects of DPSCs on neurological function and infarct size in Sprague-Dawley (SD) rats with middle cerebral artery embolization (MCAO).
Source: Journal of Stroke and Cerebrovascular Diseases - March 31, 2022 Category: Neurology Authors: Hongxia Wang, Mengjiao Sun, Jing Sun, Panpan Gong, Ning Liu, Manxia Wang Source Type: research

Cerebral dopamine neurotrophic factor increases proliferation, Migration and differentiation of subventricular zone neuroblasts in photothrombotic stroke model of mouse
Cerebral ischemic stroke can induce the proliferation of subventricular zone (SVZ) neural stem cells (NSCs) in the adult brain. However, this reparative process is restricted because of NSCs ’ death shortly after injury or disability of them to reach the infarct boundary. In the present study, we investigated the ability of cerebral dopamine neurotrophic factor (CDNF) on the attraction of SVZ-resident NSCs toward the lesioned area and neurological recovery in a photothrombotic (PT) st roke model of mice
Source: Journal of Stroke and Cerebrovascular Diseases - September 15, 2022 Category: Neurology Authors: Zahra Shabani, Hamid Soltani Zangbar, Ava Nasrolahi Source Type: research

Cell-Based Therapies for Stroke: Promising Solution or Dead End? Mesenchymal Stem Cells and Comorbidities in Preclinical Stroke Research
Conclusion The high prevalence of comorbidities in patients with stroke indicates the need for therapies in preclinical studies that take into account these comorbidities in order to avoid failures in translation to the patient. Preclinical studies are beginning to evaluate the efficacy of MSC treatment in stroke associated with comorbidities, especially hypertension, for ischemic and hemorrhagic stroke. Regarding aging and diabetes, only ischemic stroke studies have been performed. For the moment, few studies have been performed and contradictory results are being reported. These contradictory results may be due to the u...
Source: Frontiers in Neurology - April 8, 2019 Category: Neurology Source Type: research